

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Pediatric SJS-TEN: Where are we now? | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-982/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-982" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Pediatric SJS-TEN: Where are we now?" />
    
            <meta name="og:title" content="F1000Research Article: Pediatric SJS-TEN: Where are we now?.">
            <meta name="og:description" content="Read the latest article version by Michele Ramien, Jennifer L. Goldman, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22442">
            <meta name="article-id" content="20419">
            <meta name="dc.title" content="Pediatric SJS-TEN: Where are we now?">
            <meta name="dc.description" content="Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and their response to treatment. Importantly, a subset of patients with disease triggered by infection has been identified as having Mycoplasma pneumoniae&ndash;induced rash and mucositis, suggesting a reconsideration of the diagnostic paradigm. We present an update on pediatric Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis in the broader context of cutaneous adverse drug reactions and focus on challenges and recent advances in diagnosis, management, and prevention.">
            <meta name="dc.subject" content="Stevens-Johnson syndrome, toxic epidermal necrolysis, severe cutaneous drug reaction, drug reaction, drug eruption, SJS, TEN, reactive infectious mucocutaneous eruption, RIME, drug-induced epidermal necrolysis, DEN">
            <meta name="dc.creator" content="Ramien, Michele">
            <meta name="dc.creator" content="Goldman, Jennifer L.">
            <meta name="dc.date" content="2020/08/13">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20419.1">
            <meta name="dc.source" content="F1000Research 2020 9:982">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Stevens-Johnson syndrome">
            <meta name="prism.keyword" content="toxic epidermal necrolysis">
            <meta name="prism.keyword" content="severe cutaneous drug reaction">
            <meta name="prism.keyword" content="drug reaction">
            <meta name="prism.keyword" content="drug eruption">
            <meta name="prism.keyword" content="SJS">
            <meta name="prism.keyword" content="TEN">
            <meta name="prism.keyword" content="reactive infectious mucocutaneous eruption">
            <meta name="prism.keyword" content="RIME">
            <meta name="prism.keyword" content="drug-induced epidermal necrolysis">
            <meta name="prism.keyword" content="DEN">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/08/13">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="982">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20419.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-982">
            <meta name="citation_title" content="Pediatric SJS-TEN: Where are we now?">
            <meta name="citation_abstract" content="Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and their response to treatment. Importantly, a subset of patients with disease triggered by infection has been identified as having Mycoplasma pneumoniae&ndash;induced rash and mucositis, suggesting a reconsideration of the diagnostic paradigm. We present an update on pediatric Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis in the broader context of cutaneous adverse drug reactions and focus on challenges and recent advances in diagnosis, management, and prevention.">
            <meta name="citation_description" content="Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and their response to treatment. Importantly, a subset of patients with disease triggered by infection has been identified as having Mycoplasma pneumoniae&ndash;induced rash and mucositis, suggesting a reconsideration of the diagnostic paradigm. We present an update on pediatric Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis in the broader context of cutaneous adverse drug reactions and focus on challenges and recent advances in diagnosis, management, and prevention.">
            <meta name="citation_keywords" content="Stevens-Johnson syndrome, toxic epidermal necrolysis, severe cutaneous drug reaction, drug reaction, drug eruption, SJS, TEN, reactive infectious mucocutaneous eruption, RIME, drug-induced epidermal necrolysis, DEN">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Michele Ramien">
            <meta name="citation_author_institution" content="Department of Pediatrics, University of Calgary, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, AB, Canada">
            <meta name="citation_author_institution" content="Department of Medicine, University of Calgary, Calgary, AB, Canada">
            <meta name="citation_author" content="Jennifer L. Goldman">
            <meta name="citation_author_institution" content="Division of Clinical Pharmacology, Toxicology &amp; Therapeutic Innovation, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA">
            <meta name="citation_author_institution" content="Division of Pediatric Infectious Diseases, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA">
            <meta name="citation_publication_date" content="2020/08/13">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="982">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20419.1">
            <meta name="citation_firstpage" content="982">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-982/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-982.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22442 /> <input type=hidden id=articleId name=articleId value=20419 /> <input type=hidden id=xmlUrl value="/articles/9-982/v1/xml"/> <input type=hidden id=xmlFileName value="-9-982-v1.xml"> <input type=hidden id=article_uuid value=60468a09-19d0-4c20-8e58-074337fdbf7b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Pediatric SJS-TEN: Where are we now?"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20419.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20419.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-982"
  },
  "headline": "Pediatric SJS-TEN: Where are we now?",
  "datePublished": "2020-08-13T15:15:30",
  "dateModified": "2020-08-13T15:15:30",
  "author": [
    {
      "@type": "Person",
      "name": "Michele Ramien"
    },    {
      "@type": "Person",
      "name": "Jennifer L. Goldman"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and their response to treatment. Importantly, a subset of patients with disease triggered by infection has been identified as having Mycoplasma pneumoniae&ndash;induced rash and mucositis, suggesting a reconsideration of the diagnostic paradigm. We present an update on pediatric Stevens&ndash;Johnson syndrome and toxic epidermal necrolysis in the broader context of cutaneous adverse drug reactions and focus on challenges and recent advances in diagnosis, management, and prevention."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-982/v1",
            "name": "Pediatric SJS-TEN: Where are we now?"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Pediatric SJS-TEN: Where are we now? </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22442 data-id=20419 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20419.1" data-recommended="" data-doi="10.12688/f1000research.20419.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-982/v1/pdf?article_uuid=60468a09-19d0-4c20-8e58-074337fdbf7b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20419-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20419-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20419-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Ramien M and Goldman JL. Pediatric SJS-TEN: Where are we now? [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):982 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20419.1" target=_blank>https://doi.org/10.12688/f1000research.20419.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20419-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20419 id=track-article-signin-20419 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20419?target=/articles/9-982/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22442 /> <input name=articleId type=hidden value=20419 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Pediatric SJS-TEN: Where are we now?</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:michele.ramien@ucalgary.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michele Ramien</span></a><a href="https://orcid.org/0000-0001-9191-3611" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9191-3611</div><sup>1,2</sup>,&nbsp;</span><span class="">Jennifer L. Goldman<sup>3,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:michele.ramien@ucalgary.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michele Ramien</span></a><a href="http://orcid.org/0000-0001-9191-3611" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9191-3611</div><sup>1,2</sup>,&nbsp;</span><span class="">Jennifer L. Goldman<sup>3,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 13 Aug 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20419.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, University of Calgary, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, AB, Canada<br/> <sup>2</sup> Department of Medicine, University of Calgary, Calgary, AB, Canada<br/> <sup>3</sup> Division of Clinical Pharmacology, Toxicology &amp; Therapeutic Innovation, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA<br/> <sup>4</sup> Division of Pediatric Infectious Diseases, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA<br/> <p> <div class=margin-bottom> Michele Ramien <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jennifer L. Goldman <br/> <span>Roles: </span> Supervision, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=74372-69407></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=74371-69406></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> StevensJohnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and their response to treatment. Importantly, a subset of patients with disease triggered by infection has been identified as having Mycoplasma pneumoniaeinduced rash and mucositis, suggesting a reconsideration of the diagnostic paradigm. We present an update on pediatric StevensJohnson syndrome and toxic epidermal necrolysis in the broader context of cutaneous adverse drug reactions and focus on challenges and recent advances in diagnosis, management, and prevention. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Stevens-Johnson syndrome, toxic epidermal necrolysis, severe cutaneous drug reaction, drug reaction, drug eruption, SJS, TEN, reactive infectious mucocutaneous eruption, RIME, drug-induced epidermal necrolysis, DEN </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Michele Ramien (<a href="mailto:michele.ramien@ucalgary.ca">michele.ramien@ucalgary.ca</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Michele Ramien </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> MLR is the primary investigator on a study supported by the Pediatric Dermatology Research Alliance on pediatric SJS-TEN. JG is principal investigator on a study (Trimethoprim: an overlooked contributor of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions) supported by the National Institute of General Medical Sciences (5R01GM129783-02). </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2020 Ramien M and Goldman JL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Ramien M and Goldman JL. Pediatric SJS-TEN: Where are we now? [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):982 (<a href="https://doi.org/10.12688/f1000research.20419.1" target=_blank>https://doi.org/10.12688/f1000research.20419.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 13 Aug 2020, <b>9</b>(Faculty Rev):982 (<a href="https://doi.org/10.12688/f1000research.20419.1" target=_blank>https://doi.org/10.12688/f1000research.20419.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 13 Aug 2020, <b>9</b>(Faculty Rev):982 (<a href="https://doi.org/10.12688/f1000research.20419.1" target=_blank>https://doi.org/10.12688/f1000research.20419.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e170>Introduction</h2><p class="" id=d7725e173>Skin (cutaneous) reactions are among the most common types of adverse reactions to medications in children, accounting for 36% of any adverse drug reaction (ADR)<sup><a href="#ref-1">1</a></sup>. Many of these reactions are mild and self-resolving, but the rare severe ADRs can be associated with significant morbidity and even mortality. The diagnosis and treatment of cutaneous ADRs (cADRs) in children are challenging for several reasons. First, children are more commonly infected with viruses as compared with adults; each year, children in their first years of life average six to 10 respiratory viral infections and older children and adolescents average three to five such illnesses<sup><a href="#ref-2">2</a></sup>. Many of these viruses, such as EpsteinBarr virus, adenovirus, and enteroviruses, are frequently associated with cutaneous reactions that can be misinterpreted as cADRs. Second, triggers of severe cADRs, such as StevensJohnson syndrome (SJS), are different in adults and children; medications more often are implicated in adults and infections more commonly cause SJS in children<sup><a href="#ref-3">3</a></sup>. Third, causality tools currently availablefor example, Naranjo, algorithm of drug causality for epidermal necrolysis (ALDEN), and the US Food and Drug Administrations division of drug experiencehave been developed and studied primarily in adults and not applied to children. Finally, owing to the overall rarity of severe cADRs in children, there is little evidence to guide treatment.</p><p class="" id=d7725e188>ADRs can be either type A (predictable, caused by on-target drug action) or type B (heterogeneous, immunologically and metabolically mediated) (<a href="#T1">Table 1</a>). cADRs can be classified clinically by morphology and severity on the basis of the presence (complex) or absence (simple) of fever and other systemic symptoms (<a href="#T2">Table 2</a>).</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Cutaneous adverse drug reactions mechanisms summary.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e208 class=n-a></a><thead><a name=d7725e210 class=n-a></a><tr><a name=d7725e212 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e214 class=n-a></a>Type A - Augmented</th><th align=left colspan=5 rowspan=1 valign=top><a name=d7725e217 class=n-a></a>Type B - Bizarre</th></tr></thead><tbody><a name=d7725e222 class=n-a></a><tr><a name=d7725e224 class=n-a></a><td align=left colspan=1 rowspan=7 valign=top><a name=d7725e226 class=n-a></a>Predictable (example:<br class=br>overdose)</td><td align=left colspan=1 rowspan=7 valign=top><a name=d7725e231 class=n-a></a>Non-immunological<br class=br>(example:<br class=br>intolerance)</td><td align=left colspan=4 rowspan=1 valign=top><a name=d7725e238 class=n-a></a>Immunological</td></tr><tr><a name=d7725e242 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e244 class=n-a></a>Type I: IgE</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e247 class=n-a></a>Type II: IgG<br class=br>cytotoxic</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e252 class=n-a></a>Type III: immune<br class=br>complexes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e257 class=n-a></a>Type IV: delayed<br class=br>hypersensitivity</td></tr><tr><a name=d7725e263 class=n-a></a><td align=left colspan=1 rowspan=5 valign=top><a name=d7725e265 class=n-a></a>Urticaria/Angioedema</td><td align=left colspan=1 rowspan=5 valign=top><a name=d7725e268 class=n-a></a>Hemolytic<br class=br>anemia</td><td align=left colspan=1 rowspan=5 valign=top><a name=d7725e273 class=n-a></a>Vasculitis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e276 class=n-a></a>Delayed</td></tr><tr><a name=d7725e280 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e282 class=n-a></a>IVa: ACD</td></tr><tr><a name=d7725e286 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e288 class=n-a></a>IVb: DiHS/DRESS</td></tr><tr><a name=d7725e293 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e295 class=n-a></a>IVc: SJS-TEN, morbilliform</td></tr><tr><a name=d7725e299 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e301 class=n-a></a>IVd: AGEP</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d7725e309 class=n-a></a><p id=d7725e311> ACD, allergic contact dermatitis; AGEP, acute generalized exanthematous pustulosis; DiHS, drug-induced hypersensitivity syndrome; DRESS, drug reaction with eosinophilia and systemic symptoms; SJS-TEN, StevensJohnson syndrometoxic epidermal necrolysis<sup><a href="#ref-4">4</a></sup>. Adapted with permission from Noguera-Morel <i>et al</i>.<sup><a href="#ref-1">1</a></sup>.</p></div></div></div><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Morphology and severity summary.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e339 class=n-a></a><thead><a name=d7725e341 class=n-a></a><tr><a name=d7725e343 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e345 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e347 class=n-a></a>Exanthematous</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e350 class=n-a></a>Urticarial</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e353 class=n-a></a>Blistering</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e356 class=n-a></a>Pustular</th></tr></thead><tbody><a name=d7725e361 class=n-a></a><tr><a name=d7725e363 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e365 class=n-a></a>Simple  no fever</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e368 class=n-a></a>Morbilliform</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e371 class=n-a></a>Urticaria</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e374 class=n-a></a>FDE, SDRIFE</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e377 class=n-a></a>Acneiform</td></tr><tr><a name=d7725e381 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e383 class=n-a></a>Complex  fever</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e386 class=n-a></a>Drug HSS/DRESS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e389 class=n-a></a>SSLR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e392 class=n-a></a>SJS-TEN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e395 class=n-a></a>AGEP</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d7725e403 class=n-a></a><p id=d7725e405> AGEP, acute generalized exanthematous pustulosis; DRESS, drug reaction with eosinophilia and systemic symptoms; FDE, fixed drug eruption; HSS, hypersensitivity syndrome; SDRIFE, symmetrical drug related intertriginous and flexural exanthem; SJS-TEN, StevensJohnson syndrometoxic epidermal necrolysis; SSLR, serum sickness-like reaction.<sup><a href="#ref-5">5</a></sup>.</p></div></div></div><p class="" id=d7725e416>Given their rarity, complex or severe cADRs are difficult to study systematically and pediatric-specific data are limited. These challenges have led to the adoption of adult paradigms for diagnosis and management in pediatric practice, where better evidence exists.</p><p class="" id=d7725e419>In SJS and toxic epidermal necrolysis (TEN), severe blistering of the skin and mucous membranes related to either medications or infections occurs. The differential diagnosis in early cases where diffuse erythema is common may include viral exanthems, Kawasaki disease, and acute generalized exanthematous pustulosis. As widespread blistering begins to develop, thermal burns, toxic erythema of chemotherapy, pemphigus of all types, staphylococcal scalded skin syndrome (which spares the mucous membranes), acute graft-versus-host disease, acute syndrome of apoptotic pan-epidermolysis associated with systemic lupus erythematosus, and generalized bullous fixed drug eruption become the primary considerations.</p><p class="" id=d7725e422>In recent years, significant developments have occurred in the category of severe blistering drug reactionsSJS and TENthe focus of this review. The watershed evolutions in this area will be reviewed and ultimately support the need for evolution of the diagnostic categories for severe blistering cADRs in children.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e428>Incidence</h2><p class="" id=d7725e431>Until 2017, estimates of the incidence of SJS and TEN were based on retrospective surveys and databases from the 1990s and a European registry<sup><a href="#ref-6">6</a><a href="#ref-9">9</a></sup>. More recently, larger datasets have been used in attempts to better describe these rare events in pediatrics.</p><p class="" id=d7725e441>A recent US pediatric database cohort study suggests that SJS-TEN spectrum disorders occur in 7.5 per 100,000 hospitalized children<sup><a href="#ref-10">10</a></sup>; incidences of 6.3 and 0.5 per 100,000 hospitalized children per year for SJS and TEN, respectively, were reported. A second US cross-sectional study that sourced data from the same 20092012 time frame found much lower rates, of 5.3 (SJS) and 0.4 (TEN) per million children per year, in the overall population<sup><a href="#ref-11">11</a></sup>. Similar findings in both studies suggest that pediatric SJS-TEN results in a substantial health-care burden, although mortality is less when compared with adult data. There are many limitations to using large datasets to examine rare events such as SJS-TEN, including poor validity of International Classification of Diseases 9/10 (ICD-9/10) codes, inability to determine cause, and the lack of a standardized diagnostic approach across institutions. Given that the clinical features of severe cADRs can be challenging to interpret for diagnosis, standardization in case identification and validation is needed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e455>Clinical features and refining diagnosis: drug versus bug</h2><div class=section><a name=d7725e458 class=n-a></a><h3 class=section-title>StevensJohnson syndrome and toxic epidermal necrolysis</h3><p class="" id=d7725e463>SJS and TEN are characterized by blistering of the skin and mucous membranes. One to three days before onset of skin and mucosal lesions, prodromal symptoms start; these include fever, general malaise, non-productive cough, stinging eyes, and a sore mouth. These symptoms are often mistaken for an upper respiratory tract infection. Macules with purpuric, non-blanching centers with a predilection for the head and torso evolve quickly, often within 12 hours, into blisters that slough off, leaving large areas of denuded skin and mucosa. Painful erythema of the palms and soles is also common early in the disease. Target papules with three distinct rings, characteristic of erythema multiforme, a similar condition usually triggered by herpes simplex virus<sup><a href="#ref-12">12</a></sup>, are not the main morphology in SJS and TEN, although atypical two-ringed or macular (flat) targets may occur early, before blistering starts. Mucosal involvement affects oral, ocular, genitourinary, and anal sites.</p><p class="" id=d7725e470>SJS and TEN are believed to exist on a spectrum; there is less than 10% body surface area (BSA) involvement in SJS and greater than 30% BSA involvement in TEN, and intermediate BSA involvement of 10 to 30% is called SJS-TEN overlap (<a href="#T3">Table 3</a>)<sup><a href="#ref-13">13</a></sup>. Involved areas include skin that is already blistered or detached and skin that is red (macular erythema) and detachable.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Severe blistering cutaneous adverse drug reactions and <i>Mycoplasma pneumoniae</i>induced rash and mucositis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e494 class=n-a></a><thead><a name=d7725e496 class=n-a></a><tr><a name=d7725e498 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e500 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e502 class=n-a></a>SJS</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e505 class=n-a></a>SJS-TEN overlap</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e508 class=n-a></a>TEN</th></tr></thead><tbody><a name=d7725e513 class=n-a></a><tr><a name=d7725e515 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d7725e517 class=n-a></a>Body surface area affected</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e520 class=n-a></a>&lt;10%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e523 class=n-a></a>1030%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e526 class=n-a></a>&gt;30%</td></tr><tr><a name=d7725e530 class=n-a></a><td align=left colspan=3 rowspan=1 valign=top><a name=d7725e532 class=n-a></a>MIRM (usually &lt;10% but can be<br class=br>more extensive)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d7725e542 class=n-a></a><p id=d7725e544> MIRM, <i>Mycoplasma pneumoniae</i>induced rash and mucositis; SJS, StevensJohnson syndrome; TEN, toxic epidermal necrolysis.</p></div></div></div><p class="" id=d7725e553>These diagnostic categories were developed in 1993 on the basis of an expert review and synthesis of hundreds of adult cases<sup><a href="#ref-13">13</a></sup>, and for many pediatric cases, a diagnostic category can be assigned. However, problems arise when patients have severe involvement of their mucous membranes but little or no skin lesions because there is no diagnostic category for them.</p></div><div class=section><a name=d7725e561 class=n-a></a><h3 class=section-title><i>Mycoplasma pneumoniae</i>induced rash and mucositis</h3><p class="" id=d7725e568>In 2015, Canavan <i>et al.</i><sup><a href="#ref-14">14</a></sup> described <i>Mycoplasma pneumoniae</i> (MP)-induced rash and mucositis (MIRM) as an entity distinct from SJS. Patients with MIRM have exactly the features of the previously noted patients who evaded classification; they have severe mucositis of multiple mucous membranes out of proportion to skin involvement, which typically is sparse but in some cases may be significant<sup><a href="#ref-14">14</a></sup>. The characteristic constellation of features in MIRM is triggered by respiratory infection rather than medications, and pathogens other than MP have been reported<sup><a href="#ref-15">15</a></sup>. Advances in technology, including respiratory polymerase chain reaction (PCR), have improved MP detection, and more specific methods to confirm infection have recently been developed<sup><a href="#ref-16">16</a></sup>; these include measurement of MP-specific antibody-secreting cells<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d7725e597>The challenge with cases attributed to infection and with the diagnosis of MIRM is that their clinical features overlap with those of SJS, creating opportunities for patients to receive multiple diagnoses and complicating more comprehensive and systematic study of these cases in the future. Furthermore, as there is no diagnostic code in the ICD-9 or ICD-10 for MIRM, these patients would likely have been, and continue to be, assigned codes for SJS, TEN, or erythema multiforme with unreliable assignment with secondary codes for mycoplasma infection.</p></div><div class=section><a name=d7725e601 class=n-a></a><h3 class=section-title>Proposed revised classification</h3><p class="" id=d7725e606>Author MLR is part of a group that recently proposed a revised classification for severe blistering cutaneous reactions in children; the revision condenses SJS and TEN into a single category of drug-induced epidermal necrolysis (DEN) that may have variable skin involvement (manuscript under revision). This is logical because SJS and TEN are considered quantity variants of the same disease and drugs are their common trigger. The proposed classification separates out the infection-related cases typified by severe mucosal and less impressive skin lesions as reactive infectious mucocutaneous eruption (RIME). Given their disparate causes and pathogeneses, DEN and RIME have diverging management strategies: the focus is on drug withdrawal and early consideration of immunosuppressive treatment in patients with DEN and on identification and treatment of infection combined with supportive care with or without immunosuppressive therapy in RIME cases. Application of this novel pediatric-specific paradigm may have far-reaching impacts on incidence and epidemiology and ultimately provide more directed and effective management.</p><p class="" id=d7725e609>Biomarkers will likely emerge as tools to confirm diagnosis; the granulysin rapid test, which has a turnaround time of 15 minutes, was used in a 2011 report to establish an early diagnosis of SJS in a young child<sup><a href="#ref-18">18</a></sup>. Other candidate biomarkers, including eosinophilia, perforin, interferon-gamma, soluble Fas ligand, and CD69, are being evaluated, although none is validated for clinical use at this time<sup><a href="#ref-19">19</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e624>Etiologies</h2><p class="" id=d7725e627>Recent pediatric retrospective studies identify a drug as the cause of SJS and TEN in 72 to 90% of cases<sup><a href="#ref-20">20</a><a href="#ref-23">23</a></sup>. Idiopathic cases, where no cause (medication or infection) can be identified, make up 5 to 17% of cases in retrospective reviews<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a>,<a href="#ref-24">24</a></sup>. A limited number of medications, including antibiotics, anticonvulsants, and non-steroidal anti-inflammatory drugs, are implicated in the majority of pediatric cases. As stated above, MP is a common trigger of severe mucocutaneous reactions that have been considered SJS-TEN in the past; however, the clinical presentation and outcomes suggest a unique disease process.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e650>Causality and risk reduction</h2><p class="" id=d7725e653>It is important to avoid implicating medications used to treat the prodromal symptoms of SJS and TEN as causative agents<sup><a href="#ref-19">19</a></sup>. Survivors of SJS and TEN are often told to avoid all medications taken just prior to the reaction, limiting treatments that can be used for future illnesses<sup><a href="#ref-25">25</a></sup> and causing patients and families concern about the use of medications in general. Evaluation of possible implicated medications requires utilization of an effective causality tool. Many available ADR causality tools, including the Naranjo and Liverpool tools, are non-specific to the ADR phenotype. The ALDEN is specific for severe cADRs. These tools are helpful when considering the timing of drug exposure to reaction onset, the probability of drug presence in the body, prior exposure to the same drug regardless of reaction at that time, the presence of drug beyond the progression phase, drug notoriety as an ADR cause, and the presence or absence of other etiologies<sup><a href="#ref-25">25</a></sup>. Although these tools can be helpful, their usefulness is limited by variability in results between users and testing methods. Further advancements in diagnostics and assessment tools have the potential to enhance causality assessment in the future<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d7725e672>Testing to identify the causative agent in SJS-TEN remains controversial and is not widely used. <i>In vivo</i> (varied methods of re-exposure of the patient to potential trigger medications) testing includes patch testing or delayed intradermal testing. These tests can be performed once the acute reaction has resolved but within a year. Potentially cross-reacting medications can also be identified with patch testing<sup><a href="#ref-27">27</a></sup>. Unfortunately, the results are not reliable for all medications, limiting their clinical utility. Oral re-challenge, recommended for other types of drug reactions, is not recommended for SJS and TEN given the serious risk of a second potentially fatal episode<sup><a href="#ref-28">28</a></sup>. <i>In vitro</i> testing with the lymphocyte transformation test (LTT) during the recovery phase, 4 to 8 weeks after the reaction, is controversial as LTT historically has had low sensitivity in SJS-TEN and many false-positive and -negative results<sup><a href="#ref-29">29</a></sup>. Recent reports support better sensitivity (86%) and specificity (74%) in SJS-TEN, even for low-risk drugs<sup><a href="#ref-30">30</a></sup>. The drug-specific interferon-gammareleasing cell assay is highly specific (95% specificity and 79% sensitivity for allopurinol) and can be carried out in the acute phase<sup><a href="#ref-31">31</a></sup>. A recent publication highlighted its advantages over LTT: higher rates of causative drug identification (73.9% versus 52.2% for LTT) and use during the acute phase (versus recovery phase for LTT)<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d7725e706>Prevention of SJS and TEN is becoming a reality with the identification of risk factors that can be screened prior to drug initiation. Human leukocyte antigen (HLA) screening for ethnicity-specific risk alleles prior to administration of aromatic anticonvulsants (including carbamazepine), allopurinol, and abacavir reduces the risk of SJS-TEN (<a href="#T4">Table 4</a>)<sup><a href="#ref-33">33</a></sup>. Polymorphisms that reduce drug clearance can also increase the risk of severe cADRs<sup><a href="#ref-34">34</a></sup> When a risk allele is identified in a patient, the medication should be avoided<sup><a href="#ref-35">35</a></sup>. As a proof of concept, in Taiwan, where pre-carbamazepine screening for HLA-B*1502 was adopted in 2010, the incidence of SJS-TEN has drastically decreased<sup><a href="#ref-36">36</a></sup>. In Thailand, where HLA-B*1502 pre-treatment screening is also routine, HLA test results are printed on a wallet card that patients can carry with them as a pharmacogenomic ID card for future health-care interactions<sup><a href="#ref-35">35</a></sup>.</p><a name=T4 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 4. Medication causes of SJS-TEN with strongly predictive (100%) HLA associations<sup><a href="#ref-35">35</a></sup>.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e748 class=n-a></a><thead><a name=d7725e750 class=n-a></a><tr><a name=d7725e752 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e754 class=n-a></a>Medication</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e757 class=n-a></a>Population</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e760 class=n-a></a>HLA<br class=br>type</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e765 class=n-a></a>Interpretation of positive result</th></tr></thead><tbody><a name=d7725e770 class=n-a></a><tr><a name=d7725e772 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e774 class=n-a></a>Allopurinol</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e777 class=n-a></a>Han Chinese and European</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e780 class=n-a></a>B*5801</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e783 class=n-a></a>Increased risk of SJS-TEN, do not use in nave patients, can be<br class=br>considered in patients without reaction after more than 3 months</td></tr><tr><a name=d7725e789 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d7725e791 class=n-a></a>Carbamazepine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e794 class=n-a></a>Han Chinese, Thai, Malaysian,<br class=br>Indian, Singaporean, and<br class=br>Vietnamese</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e801 class=n-a></a>B*1502</td><td align=left colspan=1 rowspan=2 valign=top><a name=d7725e804 class=n-a></a>Increased risk of SJS-TEN, do not use CBZ or ox-CBZ in nave<br class=br>patients, can consider using if no reaction after more than 3 months<br class=br>treatment</td></tr><tr><a name=d7725e812 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e814 class=n-a></a>European, Japanese, and Korean</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e817 class=n-a></a>B*3101</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=TFN4 class=n-a></a><p id=d7725e827> CBZ, carbamazepine; HLA, human leukocyte antigen; ox-CBZ, oxcarbazepine; SJS-TEN, StevensJohnson syndrome  toxic epidermal necrolysis.<sup><a href="#ref-35">35</a></sup>. Adapted with permission from Peter <i>et al</i>.<sup><a href="#ref-19">19</a></sup>.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e848>To treat or not to treat, that is the question but we still dont know the answer</h2><p class="" id=d7725e851>SCORe of Toxic Epidermal Necrolysis (SCORTEN), a TEN severity-of-illness score<sup><a href="#ref-37">37</a></sup>, was developed for adults but has been used to predict both morbidity and mortality in pediatric patients<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. The SCORTEN has multiple factors, but three of themage of at least 40 years, malignancy, and heart rate of at least 120 beats per minuteare less important in children because (1) they are young, (2) they have low rates of malignancy, and (3) their normal heart rate can be over 120 beats per minute if they are younger than four. The SCORTEN, or a pediatric-adapted scoring system, could be used prospectively in studies to predict treatment efficacy by comparing actual with predicted mortality and morbidity<sup><a href="#ref-38">38</a></sup>. Despite the availability of a validated severity score that helps to predict which patients will have more severe outcomes, the absence of a gold-standard effective therapy for pediatric SJS-TEN means that the decision between supportive care and directed (immunosuppressive) therapy remains challenging.</p><p class="" id=d7725e869>In the last two years, there has been an explosion of retrospective and database publications on pediatric SJS-TEN which have come to similar conclusions on the relative lack of efficacy of corticosteroids and intravenous immunoglobulin (IVIG) on various outcomes<sup><a href="#ref-20">20</a>,<a href="#ref-22">22</a>,<a href="#ref-40">40</a><a href="#ref-43">43</a></sup>. For treatment of SJS-TEN, there is a consensus on the importance of rapid identification and withdrawal of the causative medication. As adjuvant therapy, corticosteroids are most frequently used, followed by IVIG both as monotherapy and in combination with corticosteroids. None of these mono- or combination therapies appears to affect time to healing or length of hospital stay. The best evidence on treatment before 20172018 was from a large (n = 128 cases) systematic review published in 2011 that suggested that patients who received IVIG and prednisone had better outcomes than those who received supportive care only<sup><a href="#ref-44">44</a></sup>. Overall mortality rates for SJS-TEN in newer publications range from 0 to 6.6%, and rates of up to 25% were reported for TEN cases<sup><a href="#ref-20">20</a>,<a href="#ref-22">22</a>,<a href="#ref-40">40</a><a href="#ref-43">43</a></sup>.</p><p class="" id=d7725e902>Recent case reports and case series document the rapid efficacy of cyclosporine 3 mg/kg per day divided twice a day and infliximab 5 mg/kg intravenously for one dose in both drug- and infection-related cases<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. There is emerging evidence from case reports for anti-tumor necrosis factor (anti-TNF) therapy in the acute phase<sup><a href="#ref-47">47</a><a href="#ref-50">50</a></sup>. Furthermore, a recent Taiwanese randomized clinical trial of etanercept in TEN included children older than 4 years of age and showed that etanercept (25 mg twice weekly &lt;65 kg and 50 mg if &gt;65 kg) decreased the predicted mortality rate and reduced skin healing time compared with corticosteroids (1 to 1.5 mg/kg per day intravenously) in the group as a whole<sup><a href="#ref-51">51</a></sup>. Both groups received treatment until their skin lesions healed<sup><a href="#ref-51">51</a></sup>. This study included five children who were 6 to 13 years old<sup><a href="#ref-51">51</a></sup>. Further large-scale studies are needed to confirm these promising results in the pediatric population.</p><p class="" id=d7725e931>Ocular complications and sequelae are significant for pediatric patients with SJS-TEN. Aggressive initial management, including adjuvant amniotic membrane transplantation, can reduce complications<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Even in the absence of severe ocular involvement in acute SJS-TEN, children may develop progressive disease of the ocular surface and conjunctival inflammation over time<sup><a href="#ref-54">54</a></sup>. Delayed lid margin keratinization<sup><a href="#ref-55">55</a></sup>, vision deterioration, and corneal damage can occur after SJS-TEN<sup><a href="#ref-56">56</a></sup>, emphasizing the importance of close continual follow-up by ophthalmology<sup><a href="#ref-55">55</a>,<a href="#ref-57">57</a></sup>.</p><p class="" id=d7725e961>The early introduction of psychological and social support is critical for pediatric patients with SJS-TEN to avoid long-term anxiety and depression. Ideally, the introduction should occur as soon as the patient is stable enough for a psychologist or child-life worker to visit. For children, the experience of complete loss of control of their body can be devastating, and early explanation and attention to the patients emotional needs are critical. Other chronic sequelae are summarized in <a href="#T5">Table 5</a>.</p><a name=T5 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 5. Potential chronic sequelae of StevensJohnson syndrome  toxic epidermal necrolysis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e978 class=n-a></a><thead><a name=d7725e980 class=n-a></a><tr><a name=d7725e982 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e984 class=n-a></a>Organ system</th><th align=left colspan=1 rowspan=1 valign=top><a name=d7725e987 class=n-a></a>Sequelae</th></tr></thead><tbody><a name=d7725e992 class=n-a></a><tr><a name=d7725e994 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e996 class=n-a></a>Skin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e999 class=n-a></a>Dyspigmentation, eruptive nevi, milia, nail dystrophy, alopecia, scarring, and heterotopic ossification</td></tr><tr><a name=d7725e1003 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1005 class=n-a></a>Ocular</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1008 class=n-a></a>Sicca symptoms, trichiasis, corneal vascularization, corneal scarring, symblepharon, keratitis, and blindness</td></tr><tr><a name=d7725e1012 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1014 class=n-a></a>Oral </td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1017 class=n-a></a>Xerostomia, synechiae, chronic gingivitis, dental caries, periodontal disease, taste abnormalities, abnormal<br class=br>dental development, and candidiasis</td></tr><tr><a name=d7725e1023 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1025 class=n-a></a>Gastrointestinal</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1028 class=n-a></a>Pancreatitis, colon necrosis, esophageal stenosis and webs, microstomia, and persistent intestinal ulcers</td></tr><tr><a name=d7725e1032 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1034 class=n-a></a>Genitourinary</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1037 class=n-a></a>Vaginal stenosis, labial fusion, hydrocolpos, hematocolpos, dyspareunia, vaginal dryness, and urethral stenosis</td></tr><tr><a name=d7725e1042 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1044 class=n-a></a>Pulmonary</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1047 class=n-a></a>Chronic obstructive bronchitis and bronchiolitis, bronchiectasis, and pharyngeal and laryngeal scarring</td></tr><tr><a name=d7725e1051 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1053 class=n-a></a>Autoimmune</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1056 class=n-a></a>Sjgren syndrome, systemic lupus erythematosus, and autoimmune thyroiditis</td></tr><tr><a name=d7725e1060 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1062 class=n-a></a>Psychiatric</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1065 class=n-a></a>Anxiety and depression</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d7725e1073 class=n-a></a><p id=d7725e1075> Adapted with permission from Peter <i>et al.</i>,<sup><a href="#ref-19">19</a></sup>.</p></div></div></div><div class=section><a name=d7725e1088 class=n-a></a><h3 class=section-title>Treatment of reactive infectious disease:<i> Mycoplasma pneumoniae</i> and other infections</h3><p class="" id=d7725e1096>Given the limited data on reactive infectious mucocutaneous eruptions, including MIRM and non-MP, it remains unclear whether treatment should be similar to that of SJS-TEN. A systematic review by Canavan <i>et al</i>. suggests that the majority of patients receive antibiotics and a smaller percentage receive corticosteroids, IVIGs, or supportive care only<sup><a href="#ref-14">14</a></sup>. Although antibiotics are used to treat MP respiratory infections, the effect of antibiotics on the skin and mucous membrane changes of MIRM is unclear<sup><a href="#ref-14">14</a></sup>. Recurrent disease is reported in up to 20% of patients<sup><a href="#ref-23">23</a></sup>, suggesting a genetic susceptibility to reactive mucositis and rash which has yet to be elucidated.</p><p class="" id=d7725e1114>MP-related SJS-TEN overlap has been reported in one pediatric patient to have rapidly re-epithelialized with cyclosporine 3 mg/kg per day over a period of 7 days without co-treatment for MP infection<sup><a href="#ref-45">45</a></sup>. A second case report of TEN induced by MP responded rapidly with complete resolution within a week after a single dose of infliximab 5 mg/kg per day (the patient also received meropenem)<sup><a href="#ref-46">46</a></sup>. A case series of three children whose MIRM was treated with cyclosporine suggests that the addition of cyclosporine 3 to 5 mg/kg per day for early cases may accelerate resolution compared with supportive care and antibiotics alone<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d7725e1129>Generally, the course of MIRM is less severe than for drug-related SJS-TEN, and supportive care is a reasonable option. However, the mucous membranes should be closely monitored as the same sequelae as are seen in SJS-TEN occur and can be severe. A recent publication in the ophthalmology literature suggests that these children should be followed closely during their inpatient admission similarly to SJS-TEN<sup><a href="#ref-59">59</a></sup>. In their systematic review, Canavan <i>et al</i>. reported ocular sequelae in 9%, post-inflammatory dyspigmentation in 6%, and oral or genital synechiae in less than 1%<sup><a href="#ref-14">14</a></sup>. Severe gynecologic sequelae requiring surgery have been reported<sup><a href="#ref-60">60</a></sup>. Given the sequelae and the acute severe disease course, psychosocial support should ideally be introduced to patients and families at the time of diagnosis (as for SJS-TEN) and there should be a regular review for signs of (latent) distress at follow-up visits to their primary care provider.</p><p class="" id=d7725e1147>The bottom line for therapy is that the identified triggering medication should be discontinued, an infection should be sought and treated if suspected, supportive care in a low-ratio nursing environment should be provided, and anti-inflammatory immunosuppressive therapy, particularly in the early acute phase, should be considered. Specialist input should be sought and coordinated. An overview of the approach to practical management of pediatric SJS-TEN is presented in <a href="#T6">Table 6</a> and is detailed by McPherson <i>et al</i>.<sup><a href="#ref-62">62</a></sup>.</p><a name=T6 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 6. Practical management of pediatric StevensJohnson syndrome  toxic epidermal necrolysis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d7725e1172 class=n-a></a><tbody><a name=d7725e1174 class=n-a></a><tr><a name=d7725e1176 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1178 class=n-a></a>Admission</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1181 class=n-a></a>Determine cause based on drug history (ALDEN), infectious symptoms<br class=br><b>Baseline:</b><br class=br>Investigations: confirm cause, rule out contraindications to treatment<br class=br>- routine bloodwork, including complete metabolic profile, liver function tests, urinalysis<br class=br>- infectious workup, including viral serologies/PCR (EpsteinBarr virus, cytomegalovirus, HSV, human herpes virus 6),<br class=br>nasopharyngeal swab for respiratory viruses and <i>Mycoplasma pneumoniae</i> PCR, oral mucosal swab for HSV PCR, chest<br class=br>x-ray to rule out pneumonia<br class=br>- screen for HLA risk alleles if not already known (<a href="#T4">Table 4</a>)<br class=br>- if patient severe and might need immunosuppression: consider interferon-gamma release assay for tuberculosis,<br class=br>hepatitis and HIV serology, <i>Strongyloides serology</i><br class=br>Document severity: SCORTEN, BSA, photography<br class=br><b>Treatment:</b><br class=br>Discontinue potential causative medications<br class=br>Treat for infection if present with directed antibiotics<br class=br>Supportive care: sterile wound care, fluid replacement and nutritional supplementation as for burns, airway management,<br class=br>pain control<br class=br><b>Plan:</b><br class=br>Assess need for transfer to specialized experienced center for severe cases (SCORTEN &gt;1, BSA &gt;10%, comorbidities,<br class=br>requiring ventilation)<br class=br>Consult dermatology, ophthalmology, gynecology, urology, infectious disease, pharmacy/clinical pharmacology urgently<br class=br>Consider anti-inflammatory/immunosuppressive treatment: consider contraindications, risk-benefit</td></tr><tr><a name=d7725e1239 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1241 class=n-a></a>Monitoring</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1244 class=n-a></a>Frequent vital signs, monitor for fever<br class=br>Frequent swabs to identify infection early, prophylactic antibiotics not recommended<br class=br>Document progression with SCORTEN, photography<br class=br>Supportive care, including early physiotherapy</td></tr><tr><a name=d7725e1254 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1256 class=n-a></a>Follow-up</td><td align=left colspan=1 rowspan=1 valign=top><a name=d7725e1259 class=n-a></a>Identify a primary contact for the patient after discharge, either a pediatrician or specialist amongst the following:<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dermatology<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ophthalmology<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gastroenterology<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gynecology (female) and urology (male)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Psychiatry/Psychology for post-traumatic stress disorder<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Genetics to review HLA testing and counsel family<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Respirology if needed<br class=br>Consider <i>in vitro</i> testing with lymphocyte transformation test or ELISpot (controversial)<br class=br>Give patient a wallet card that identifies their history of SJS-TEN and HLA screening result for future medical encounters. Please refer to Figure 4 in Sukasem <i>et al</i>.<sup><a href="#ref-35">35</a></sup> for an example.</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d7725e1297 class=n-a></a><p id=d7725e1299> ALDEN, algorithm of drug causality for epidermal necrolysis; BSA, body surface area; HLA, human leukocyte antigen; HSV, herpes simplex virus; PCR, polymerase chain reaction; SCORTEN, SCORe of Toxic Epidermal Necrolysis; SJS-TEN, StevensJohnson syndrome  toxic epidermal necrolysis.<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>.</p></div></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e1316>How redefining diagnosis of pediatric StevensJohnson syndrome  toxic epidermal necrolysis can improve treatment</h2><p class="" id=d7725e1319>The literature on the treatment of pediatric SJS and TEN is disappointing as larger studies suggest no impact of any intervention other than drug withdrawal. In contrast, case series and reports document the effectiveness of various anti-inflammatory immunosuppressive treatments. Could it be that the way that past cases are classified results in groups that are too heterogeneous (that is, triggered by infection or drugs or idiopathic) to respond similarly to a given therapy? Considering a shift in diagnostic paradigm as discussed above may be a way to interpret the existing literature with a lens focused from cause/trigger to treatment. Adding to this a precision medicine approach that compares subpopulations of responders with non-responders to identify characteristics that permit early recognition and takes advantage of biomarkers like the granulysin rapid test may lead to a future in which we can select the right treatment for the right patient every time.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e1325>Conclusions</h2><p class="" id=d7725e1328>The future is bright for pediatric SJS-TEN. Initiatives are under way to improve our understanding of this spectrum of disorders, specifically in children. A British guideline on management was recently published<sup><a href="#ref-61">61</a></sup>. With increasing accessibility and validation of risk factor screening (HLA and metabolism variants) and biomarkers, we may soon be able to prevent SJS-TEN in predisposed individuals and diagnose and treat it early when it occurs by chance.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7725e1338>Abbreviations</h2><p class="" id=d7725e1341>ADR, adverse drug reaction; ALDEN, algorithm of drug causality for epidermal necrolysis; BSA, body surface area; cADR, cutaneous adverse drug reaction; DEN, drug-induced epidermal necrolysis; HLA, human leukocyte antigen; ICD, International Classification of Diseases; IVIG, intravenous immunoglobulin; LTT, lymphocyte transformation test; MIRM, <i>Mycoplasma pneumoniae</i>induced rash and mucositis; MP, <i>Mycoplasma pneumoniae</i>; RIME, reactive infectious mucocutaneous eruption; SCORTEN, SCORe of Toxic Epidermal Necrolysis; SJS, StevensJohnson syndrome; TEN, toxic epidermal necrolysis</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d7725e1354 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class=faculty-opinion-icon></span><span class="prime-red big">Faculty Opinions recommended</span></span><h2 class=main-title id=d8146>References</h2><div class="section ref-list"><a name=d7725e1354 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d7725e1361 class=n-a></a>Noguera-Morel L, Hernndez-Martn , Torrelo A: Cutaneous drug reactions in the pediatric population. <i>Pediatr Clin North Am.</i> 2014; <b>61</b>(2): 40326. <a target=xrefwindow id=d7725e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/24636653">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1372 href="https://doi.org/10.1016/j.pcl.2013.12.001">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d7725e1381 class=n-a></a>Pavia AT: Viral infections of the lower respiratory tract: Old viruses, new viruses, and the role of diagnosis. <i>Clin Infect Dis.</i> 2011; <b>52 Suppl 4</b>(Suppl 4): S2849. <a target=xrefwindow id=d7725e1389 href="http://www.ncbi.nlm.nih.gov/pubmed/21460286">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1392 href="https://doi.org/10.1093/cid/cir043">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3106235">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727381476"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1404 class=n-a></a>Paulmann M, Mockenhaupt M: Fever in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases: Laboratory Work-up and Antibiotic Therapy. <i>Pediatr Infect Dis J.</i> 2017; <b>36</b>(5): 513515. <a target=xrefwindow id=d7725e1412 href="http://www.ncbi.nlm.nih.gov/pubmed/28403057">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1415 href="https://doi.org/10.1097/INF.0000000000001571">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727381476">Faculty Opinions Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d7725e1428 class=n-a></a>Coombs P, Gell PGH: Classification of Allergic Reactions Responsible for Clinical Hypersensitivity and Disease. In: Clinical Aspects of Immunology. Oxford: 2nd ed.; <b>1968</b>: 575596. <a target=xrefwindow id=d7725e1433 href="https://www.karger.com/Article/FullText/453265">Reference Source</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d7725e1442 class=n-a></a>Dodiuk-Gad RP, Chung WH, Shear NH: Adverse Medication Reactions. (Gaspari AA Tyring SK Kaplan DH eds.). Cham: Springer International Publishing; 2017. <a target=xrefwindow id=d7725e1444 href="https://doi.org/10.1007/978-3-319-29785-9_25">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1447 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7123512">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d7725e1457 class=n-a></a>Roujeau JC, Guillaume JC, Fabre JP, <i> et al.</i>: Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. <i>Arch Dermatol.</i> 1990; <b>126</b>(1): 3742. <a target=xrefwindow id=d7725e1468 href="http://www.ncbi.nlm.nih.gov/pubmed/2134982">PubMed Abstract </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d7725e1477 class=n-a></a>Chan HL, Stern RS, Arndt KA, <i> et al.</i>: The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. <i>Arch Dermatol.</i> 1990; <b>126</b>(1): 437. <a target=xrefwindow id=d7725e1488 href="http://www.ncbi.nlm.nih.gov/pubmed/2404462">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1491 href="https://doi.org/10.1001/archderm.1990.01670250049006">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d7725e1500 class=n-a></a>Rzany B, Mockenhaupt M, Baur S, <i> et al.</i>: Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): Structure and results of a population-based registry. <i>J Clin Epidemiol.</i> 1996; <b>49</b>(7): 76973. <a target=xrefwindow id=d7725e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/8691227">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1514 href="https://doi.org/10.1016/0895-4356(96)00035-2">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d7725e1523 class=n-a></a>Strom BL, Carson JL, Halpern AC, <i> et al.</i>: A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. <i>Arch Dermatol.</i> 1991; <b>127</b>(6): 8318. <a target=xrefwindow id=d7725e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/2036028">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1537 href="https://doi.org/10.1001/archderm.1991.01680050075007">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d7725e1546 class=n-a></a>Antoon JW, Goldman JL, Lee B, <i> et al.</i>: Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. <i>Pediatr Dermatol.</i> 2018; <b>35</b>(2): 182187. <a target=xrefwindow id=d7725e1557 href="http://www.ncbi.nlm.nih.gov/pubmed/29315761">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1560 href="https://doi.org/10.1111/pde.13383">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727397655"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1569 class=n-a></a>Hsu DY, Brieva J, Silverberg NB, <i> et al.</i>: Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(5): 811817.e4. <a target=xrefwindow id=d7725e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/28285784">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1583 href="https://doi.org/10.1016/j.jaad.2016.12.024">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1587 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5502094">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727397655">Faculty Opinions Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d7725e1601 class=n-a></a>Auquier-Dunant A, Mockenhaupt M, Naldi L, <i> et al.</i>: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. <i>Arch Dermatol.</i> 2002; <b>138</b>(8): 101924. <a target=xrefwindow id=d7725e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/12164739">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1615 href="https://doi.org/10.1001/archderm.138.8.1019">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d7725e1624 class=n-a></a>Bastuji-Garin S, Rzany B, Stern RS, <i> et al.</i>: Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme. <i>Arch Dermatol.</i> 1993; <b>129</b>(1): 9296. <a target=xrefwindow id=d7725e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/8420497">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1638 href="https://doi.org/10.1001/archderm.1993.01680220104023">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/725333679"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1647 class=n-a></a>Canavan TN, Mathes EF, Frieden I, <i> et al.</i>: <i>Mycoplasma pneumoniae</i>-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review. <i>J Am Acad Dermatol.</i> 2015; <b>72</b>(2): 23945. <a target=xrefwindow id=d7725e1661 href="http://www.ncbi.nlm.nih.gov/pubmed/25592340">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1665 href="https://doi.org/10.1016/j.jaad.2014.06.026">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/725333679">Faculty Opinions Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727691262"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1678 class=n-a></a>Mayor-Ibarguren A, Feito-Rodriguez M, Gonzlez-Ramos J, <i> et al.</i>: Mucositis Secondary to <i>Chlamydia pneumoniae</i> Infection: Expanding the <i>Mycoplasma pneumoniae</i>-Induced Rash and Mucositis Concept. <i>Pediatr Dermatol.</i> 2017; <b>34</b>(4): 465472. <a target=xrefwindow id=d7725e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/28568680">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1699 href="https://doi.org/10.1111/pde.13140">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727691262">Faculty Opinions Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733893491"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1712 class=n-a></a>Meyer Sauteur PM, Unger WWJ, van Rossum AMC, <i> et al.</i>: The Art and Science of Diagnosing <i>Mycoplasma pneumoniae</i> Infection. <i>Pediatr Infect Dis J.</i> 2018; <b>37</b>(11): 11921195. <a target=xrefwindow id=d7725e1726 href="http://www.ncbi.nlm.nih.gov/pubmed/30169485">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1730 href="https://doi.org/10.1097/INF.0000000000002171">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733893491">Faculty Opinions Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736591269"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1743 class=n-a></a>Meyer Sauteur PM, Seiler M, Trck J, <i> et al.</i>: Diagnosis of <i>Mycoplasma pneumoniae</i> Pneumonia with Measurement of Specific Antibody-Secreting Cells. <i>Am J Respir Crit Care Med.</i> 2019; <b>200</b>(8): 10661069. <a target=xrefwindow id=d7725e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/31251669">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1761 href="https://doi.org/10.1164/rccm.201904-0860LE">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1764 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6794114">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736591269">Faculty Opinions Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/12485956"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1778 class=n-a></a>Fujita Y, Yoshioka N, Abe R, <i> et al.</i>: Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. <i>J Am Acad Dermatol.</i> 2011; <b>65</b>(1): 658. <a target=xrefwindow id=d7725e1789 href="http://www.ncbi.nlm.nih.gov/pubmed/21507517">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1792 href="https://doi.org/10.1016/j.jaad.2010.04.042">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/12485956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727591105"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1805 class=n-a></a>Peter JG, Lehloenya R, Dlamini S, <i> et al.</i>: Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. <i>J Allergy Clin Immunol Pract.</i> 2017; <b>5</b>(3): 547563. <a target=xrefwindow id=d7725e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/28483310">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1819 href="https://doi.org/10.1016/j.jaip.2017.01.025">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5424615">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727591105">Faculty Opinions Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734602248"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1836 class=n-a></a>Chatproedprai S, Wutticharoenwong V, Tempark T, <i> et al.</i>: Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital. <i>Dermatol Res Pract.</i> 2018; <b>2018</b>: 3061084. <a target=xrefwindow id=d7725e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/29853855">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1850 href="https://doi.org/10.1155/2018/3061084">Publisher Full Text </a> | <a target=xrefwindow id=d7725e1854 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5964615">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734602248">Faculty Opinions Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d7725e1867 class=n-a></a>Quirke KP, Beck A, Gamelli RL, <i> et al.</i>: A 15-year review of pediatric toxic epidermal necrolysis. <i>J Burn Care Res.</i> 2015; <b>36</b>(1): 1306. <a target=xrefwindow id=d7725e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/25501779">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1881 href="https://doi.org/10.1097/BCR.0000000000000208">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727460670"><span class="faculty-opinion-icon small"></span></a><a name=d7725e1890 class=n-a></a>Dibek Misirlioglu E, Guvenir H, Bahceci S, <i> et al.</i>: Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study. <i>J Allergy Clin Immunol Pract.</i> 2017; <b>5</b>(3): 757763. <a target=xrefwindow id=d7725e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/28351788">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1904 href="https://doi.org/10.1016/j.jaip.2017.02.013">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727460670">Faculty Opinions Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d7725e1917 class=n-a></a>Finkelstein Y, Soon GS, Acuna P, <i> et al.</i>: Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. <i>Pediatrics.</i> 2011; <b>128</b>(4): 7238. <a target=xrefwindow id=d7725e1928 href="http://www.ncbi.nlm.nih.gov/pubmed/21890829">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1931 href="https://doi.org/10.1542/peds.2010-3322">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d7725e1941 class=n-a></a>Levi N, Bastuji-Garin S, Mockenhaupt M, <i> et al.</i>: Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. <i>Pediatrics.</i> 2009; <b>123</b>(2): e297e304. <a target=xrefwindow id=d7725e1952 href="http://www.ncbi.nlm.nih.gov/pubmed/19153164">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1955 href="https://doi.org/10.1542/peds.2008-1923">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d7725e1964 class=n-a></a>Sassolas B, Haddad C, Mockenhaupt M, <i> et al.</i>: ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. <i>Clin Pharmacol Ther.</i> 2010; <b>88</b>(1): 608. <a target=xrefwindow id=d7725e1975 href="http://www.ncbi.nlm.nih.gov/pubmed/20375998">PubMed Abstract </a> | <a target=xrefwindow id=d7725e1978 href="https://doi.org/10.1038/clpt.2009.252">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d7725e1987 class=n-a></a>Goldman JL, Chung WH, Lee BR, <i> et al.</i>: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. <i>Eur J Clin Pharmacol.</i> 2019; <b>75</b>(8): 113541. <a target=xrefwindow id=d7725e1998 href="http://www.ncbi.nlm.nih.gov/pubmed/30918988">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2001 href="https://doi.org/10.1007/s00228-019-02670-9">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2005 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6659414">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d7725e2014 class=n-a></a>Lin YT, Chang YC, Hui RCY, <i> et al.</i>: A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions. <i>J Eur Acad Dermatol Venereol.</i> 2013; <b>27</b>(3): 35664. <a target=xrefwindow id=d7725e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/22211830">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2028 href="https://doi.org/10.1111/j.1468-3083.2011.04418.x">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d7725e2037 class=n-a></a>Aberer W, Bircher A, Romano A, <i> et al.</i>: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. <i>Allergy.</i> 2003; <b>58</b>(9): 85463. <a target=xrefwindow id=d7725e2048 href="http://www.ncbi.nlm.nih.gov/pubmed/12911412">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2051 href="https://doi.org/10.1034/j.1398-9995.2003.00279.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/1097077"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2060 class=n-a></a>Kano Y, Hirahara K, Mitsuyama Y, <i> et al.</i>: Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. <i>Allergy.</i> 2007; <b>62</b>(12): 143944. <a target=xrefwindow id=d7725e2071 href="http://www.ncbi.nlm.nih.gov/pubmed/17983378">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2074 href="https://doi.org/10.1111/j.1398-9995.2007.01553.x">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/1097077">Faculty Opinions Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736672749"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2088 class=n-a></a>Belln T, Rodrguez-Martn S, Cabaas R, <i> et al.</i>: Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN. <i>Allergy.</i> 2020; <b>75</b>(4): 956959. <a target=xrefwindow id=d7725e2099 href="http://www.ncbi.nlm.nih.gov/pubmed/31557316">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2102 href="https://doi.org/10.1111/all.14062">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736672749">Faculty Opinions Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d7725e2115 class=n-a></a>Klaewsongkram J, Thantiworasit P, Suthumchai N, <i> et al.</i>: <i>In vitro</i> test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions. <i>Br J Dermatol.</i> 2016; <b>175</b>(5): 9941002. <a target=xrefwindow id=d7725e2129 href="http://www.ncbi.nlm.nih.gov/pubmed/27106261">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2133 href="https://doi.org/10.1111/bjd.14701">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732758002"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2142 class=n-a></a>Suthumchai N, Srinoulprasert Y, Thantiworasit P, <i> et al.</i>: The measurement of drug-induced interferon -releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions. <i>J Eur Acad Dermatol Venereol.</i> 2018; <b>32</b>(6): 9928. <a target=xrefwindow id=d7725e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/29478292">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2156 href="https://doi.org/10.1111/jdv.14890">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732758002">Faculty Opinions Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d7725e2169 class=n-a></a>Ferrandiz-Pulido C, Garcia-Patos V: A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. <i>Arch Dis Child.</i> 2013; <b>98</b>(12): 9981003. <a target=xrefwindow id=d7725e2177 href="http://www.ncbi.nlm.nih.gov/pubmed/23873883">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2180 href="https://doi.org/10.1136/archdischild-2013-303718">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d7725e2189 class=n-a></a>Chung WH, Chang WC, Lee YS, <i> et al.</i>: Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions. <i>JAMA</i> 2014; <b>312</b>(5): 52534. <a target=xrefwindow id=d7725e2200 href="http://www.ncbi.nlm.nih.gov/pubmed/25096692">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2203 href="https://doi.org/10.1001/jama.2014.7859">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733039594"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2212 class=n-a></a>Sukasem C, Katsila T, Tempark T, <i> et al.</i>: Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics. <i>Annu Rev Genomics Hum Genet.</i> 2018; <b>19</b>: 32953. <a target=xrefwindow id=d7725e2223 href="http://www.ncbi.nlm.nih.gov/pubmed/29652519">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2226 href="https://doi.org/10.1146/annurev-genom-083115-022324">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733039594">Faculty Opinions Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d7725e2240 class=n-a></a>White KD, Chung WH, Hung SI, <i> et al.</i>: Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. <i>J Allergy Clin Immunol.</i> 2015; <b>136</b>(2): 21934. <a target=xrefwindow id=d7725e2251 href="http://www.ncbi.nlm.nih.gov/pubmed/26254049">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2254 href="https://doi.org/10.1016/j.jaci.2015.05.050">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2258 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4577472">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d7725e2267 class=n-a></a>Fouchard N, Bertocchi M, Roujeau JC, <i> et al.</i>: SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis. <i>J Invest Dermatol.</i> 2000; <b>115</b>(2): 14953. <a target=xrefwindow id=d7725e2278 href="http://www.ncbi.nlm.nih.gov/pubmed/10951229">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2281 href="https://doi.org/10.1046/j.1523-1747.2000.00061.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727626696"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2290 class=n-a></a>Sorrell J, Anthony L, Rademaker A, <i> et al.</i>: Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis. <i>Pediatr Dermatol.</i> 2017; <b>34</b>(4): 4337. <a target=xrefwindow id=d7725e2301 href="http://www.ncbi.nlm.nih.gov/pubmed/28508417">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2304 href="https://doi.org/10.1111/pde.13172">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727626696">Faculty Opinions Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d7725e2317 class=n-a></a>Beck A, Quirke KP, Gamelli RL, <i> et al.</i>: Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough. <i>J Burn Care Res.</i> 2015; <b>36</b>(1): 16777. <a target=xrefwindow id=d7725e2328 href="http://www.ncbi.nlm.nih.gov/pubmed/25559731">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2331 href="https://doi.org/10.1097/BCR.0000000000000204">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733367813"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2340 class=n-a></a>Antoon JW, Goldman JL, Shah SS, <i> et al.</i>: A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. <i>J Allergy Clin Immunol Pract.</i> 2019; <b>7</b>(1): 244250.e1. <a target=xrefwindow id=d7725e2351 href="http://www.ncbi.nlm.nih.gov/pubmed/29859332">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2354 href="https://doi.org/10.1016/j.jaip.2018.05.024">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2358 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7014963">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733367813">Faculty Opinions Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734933238"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2371 class=n-a></a>Oh HL, Kang DY, Kang HR, <i> et al.</i>: Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry. <i>Allergy Asthma Immunol Res.</i> 2019; <b>11</b>(2): 24153. <a target=xrefwindow id=d7725e2382 href="http://www.ncbi.nlm.nih.gov/pubmed/30661316">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2385 href="https://doi.org/10.4168/aair.2019.11.2.241">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6340806">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734933238">Faculty Opinions Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733432916"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2403 class=n-a></a>Sato S, Kanbe T, Tamaki Z, <i> et al.</i>: Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. <i>Pediatr Int.</i> 2018; <b>60</b>(8): 697702. <a target=xrefwindow id=d7725e2414 href="https://doi.org/10.1111/ped.13613.">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733432916">Faculty Opinions Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/726782364"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2427 class=n-a></a>Techasatian L, Panombualert S, Uppala R, <i> et al.</i>: Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital. <i>World J Pediatr.</i> 2017; <b>13</b>(3): 25560. <a target=xrefwindow id=d7725e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/27650525">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2441 href="https://doi.org/10.1007/s12519-016-0057-3">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/726782364">Faculty Opinions Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d7725e2454 class=n-a></a>Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, <i> et al.</i>: A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. <i>J Popul Ther Clin Pharmacol.</i> 2011; <b>18</b>: e12133. <a target=xrefwindow id=d7725e2465 href="http://www.ncbi.nlm.nih.gov/pubmed/21467603">PubMed Abstract </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736595678"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2474 class=n-a></a>St. John J, Ratushny V, Liu KJ, <i> et al.</i>: Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children. <i>Pediatr Dermatol.</i> 2017; <b>34</b>(5): 5406. <a target=xrefwindow id=d7725e2485 href="http://www.ncbi.nlm.nih.gov/pubmed/28884910">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2488 href="https://doi.org/10.1111/pde.13236">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736595678">Faculty Opinions Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735401227"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2501 class=n-a></a>Chafranska L, Saunte DM, Behrendt N, <i> et al.</i>: Pediatric toxic epidermal necrolysis treated successfully with infliximab. <i>Pediatr Dermatol.</i> 2019; <b>36</b>(3): 3425. <a target=xrefwindow id=d7725e2512 href="http://www.ncbi.nlm.nih.gov/pubmed/30834560">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2515 href="https://doi.org/10.1111/pde.13778">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735401227">Faculty Opinions Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d7725e2528 class=n-a></a>Scott-Lang V, Tidman M, McKay D: Toxic epidermal necrolysis in a child successfully treated with infliximab. <i>Pediatr Dermatol.</i> 2014; <b>31</b>(4): 5324. <a target=xrefwindow id=d7725e2536 href="http://www.ncbi.nlm.nih.gov/pubmed/23072342">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2539 href="https://doi.org/10.1111/pde.12029">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d7725e2549 class=n-a></a>Wojtkiewicz A, Wysocki M, Fortuna J, <i> et al.</i>: Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. <i>Acta Derm Venereol.</i> 2008; <b>88</b>(4): 4201. <a target=xrefwindow id=d7725e2560 href="http://www.ncbi.nlm.nih.gov/pubmed/18709327">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2563 href="https://doi.org/10.2340/00015555-0462">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d7725e2572 class=n-a></a>Zrate-Correa LC, Carrillo-Gmez DC, Ramrez-Escobar AF, <i> et al.</i>: Toxic epidermal necrolysis successfully treated with infliximab. <i>J Investig Allergol Clin Immunol.</i> 2013; <b>23</b>(1): 613. <a target=xrefwindow id=d7725e2583 href="http://www.ncbi.nlm.nih.gov/pubmed/23653980">PubMed Abstract </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d7725e2592 class=n-a></a>Gavigan GM, Kanigsberg ND, Ramien ML: Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept. <i>J Cutan Med Surg.</i> 2018; <b>22</b>(5): 5145. <a target=xrefwindow id=d7725e2600 href="http://www.ncbi.nlm.nih.gov/pubmed/29421925">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2603 href="https://doi.org/10.1177/1203475418758989">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732604709"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2612 class=n-a></a>Wang CW, Yang LY, Chen CB, <i> et al.</i>: Randomized, controlled trial of TNF- antagonist in CTL-mediated severe cutaneous adverse reactions. <i>J Clin Invest.</i> 2018; <b>128</b>(3): 98596. <a target=xrefwindow id=d7725e2623 href="http://www.ncbi.nlm.nih.gov/pubmed/29400697">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2626 href="https://doi.org/10.1172/JCI93349">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5824923">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732604709">Faculty Opinions Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d7725e2643 class=n-a></a>Sharma N, Thenarasun SA, Kaur M, <i> et al.</i>: Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial. <i>Ophthalmology.</i> 2016; <b>123</b>(3): 48491. <a target=xrefwindow id=d7725e2654 href="http://www.ncbi.nlm.nih.gov/pubmed/26686968">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2657 href="https://doi.org/10.1016/j.ophtha.2015.10.027">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d7725e2666 class=n-a></a>Kohanim S, Palioura S, Saeed HN, <i> et al.</i>: Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. <i>Ocul Surf.</i> 2016; <b>14</b>(2): 16888. <a target=xrefwindow id=d7725e2677 href="http://www.ncbi.nlm.nih.gov/pubmed/26882981">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2680 href="https://doi.org/10.1016/j.jtos.2016.02.001">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d7725e2690 class=n-a></a>de Rojas MV, Dart JKG, Saw VPJ: The natural history of Stevens Johnson syndrome: Patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. <i>Br J Ophthalmol.</i> 2007; <b>91</b>(8): 104853. <a target=xrefwindow id=d7725e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/17314145">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2701 href="https://doi.org/10.1136/bjo.2006.109124">Publisher Full Text </a> | <a target=xrefwindow id=d7725e2704 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1954786">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d7725e2713 class=n-a></a>Catt CJ, Hamilton GM, Fish J, <i> et al.</i>: Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. <i>Am J Ophthalmol.</i> 2016; <b>166</b>: 6875. <a target=xrefwindow id=d7725e2724 href="http://www.ncbi.nlm.nih.gov/pubmed/27018234">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2727 href="https://doi.org/10.1016/j.ajo.2016.03.020 ">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d7725e2736 class=n-a></a>Iyer G, Srinivasan B, Agarwal S, <i> et al.</i>: Treatment Modalities and Clinical Outcomes in Ocular Sequelae of Stevens-Johnson Syndrome Over 25 Years--A Paradigm Shift. <i>Cornea.</i> 2016; <b>35</b>(1): 4650. <a target=xrefwindow id=d7725e2747 href="http://www.ncbi.nlm.nih.gov/pubmed/26555585">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2750 href="https://doi.org/10.1097/ICO.0000000000000680">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732629480"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2759 class=n-a></a>Basu S, Shanbhag SS, Gokani A, <i> et al.</i>: Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease. <i>Am J Ophthalmol.</i> 2018; <b>189</b>: 1728. <a target=xrefwindow id=d7725e2770 href="http://www.ncbi.nlm.nih.gov/pubmed/29421293">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2773 href="https://doi.org/10.1016/j.ajo.2018.01.028 ">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732629480">Faculty Opinions Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d7725e2786 class=n-a></a>Li HOY, Colantonio S, Ramien ML: Treatment of <i>Mycoplasma pneumoniae</i>-Induced Rash and Mucositis With Cyclosporine [Formula: see text]. <i>J Cutan Med Surg.</i> 2019; <b>23</b>(6): 60812. <a target=xrefwindow id=d7725e2797 href="http://www.ncbi.nlm.nih.gov/pubmed/31502864">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2800 href="https://doi.org/10.1177/1203475419874444">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736067032"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2809 class=n-a></a>Shah PR, Williams AM, Pihlblad MS, <i> et al.</i>: Ophthalmic Manifestations of Mycoplasma-Induced Rash and Mucositis. <i>Cornea.</i> 2019; <b>38</b>(10): 13058. <a target=xrefwindow id=d7725e2820 href="http://www.ncbi.nlm.nih.gov/pubmed/31246679">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2823 href="https://doi.org/10.1097/ICO.0000000000001985">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736067032">Faculty Opinions Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d7725e2837 class=n-a></a>Pliskow S: Severe gynecologic sequelae of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by ibuprofen: a case report. <i>J Reprod Med.</i> 2013; <b>58</b>(78): 3546. <a target=xrefwindow id=d7725e2845 href="http://www.ncbi.nlm.nih.gov/pubmed/23947089">PubMed Abstract </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735241321"><span class="faculty-opinion-icon small"></span></a><a name=d7725e2854 class=n-a></a>McPherson T, Exton LS, Biswas S, <i> et al.</i>: British Association of Dermatologists' guidelines for the management of StevensJohnson syndrome/toxic epidermal necrolysis in children and young people, 2018. <i>Br J Dermatol.</i> 2019; <b>181</b>(1): 3754. <a target=xrefwindow id=d7725e2865 href="http://www.ncbi.nlm.nih.gov/pubmed/30829411">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2868 href="https://doi.org/10.1111/bjd.17841">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735241321">Faculty Opinions Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d7725e2881 class=n-a></a>Maverakis E, Wang EA, Shinkai K, <i> et al.</i>: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. <i>JAMA Dermatol.</i> 2017; <b>153</b>(6): 58792. <a target=xrefwindow id=d7725e2892 href="http://www.ncbi.nlm.nih.gov/pubmed/28296986">PubMed Abstract </a> | <a target=xrefwindow id=d7725e2895 href="https://doi.org/ 10.1001/jamadermatol.2017.0160">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-982/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-982/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, University of Calgary, Alberta Children's Hospital, 28 Oki Dr NW, Calgary, AB, Canada<br/> <sup>2</sup> Department of Medicine, University of Calgary, Calgary, AB, Canada<br/> <sup>3</sup> Division of Clinical Pharmacology, Toxicology &amp; Therapeutic Innovation, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA<br/> <sup>4</sup> Division of Pediatric Infectious Diseases, Children&rsquo;s Mercy Hospitals and Clinics, Kansas City, MO, USA<br/> <p> <div class=margin-bottom> Michele Ramien <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jennifer L. Goldman <br/> <span>Roles: </span> Supervision, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-982/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 13 Aug 2020, 9:982 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20419.1">https://doi.org/10.12688/f1000research.20419.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2020 Ramien M and Goldman JL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22442 data-id=20419 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20419.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-982/v1/pdf?article_uuid=60468a09-19d0-4c20-8e58-074337fdbf7b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20419.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Ramien M and Goldman JL. Pediatric SJS-TEN: Where are we now? [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):982 (<a href="https://doi.org/10.12688/f1000research.20419.1" target=_blank>https://doi.org/10.12688/f1000research.20419.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20419 id=mobile-track-article-signin-20419 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20419?target=/articles/9-982/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22442 /> <input name=articleId type=hidden value=20419 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Teresa Bell&oacute;n</strong>, La Paz Hospital Health Research Institute-IdiPAZ, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Sayan Basu</strong>, The Cornea Institute, L V Prasad Eye Institute (LVPEI), India </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-982/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-982/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=74372-69407></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=74371-69406></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-982/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>13 Aug 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Teresa Bell&oacute;n</strong>, La Paz Hospital Health Research Institute-IdiPAZ, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sayan Basu</strong>, The Cornea Institute, L V Prasad Eye Institute (LVPEI), India </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-982/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-982/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Pediatric SJS-TEN: Where are we now?".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-982/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-982/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-982/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Ramien M and Goldman JL');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-982/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-982",
            templates : {
                twitter : "Pediatric SJS-TEN: Where are we now?. Ramien M and Goldman JL, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-982/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Pediatric SJS-TEN: Where are we now?", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Pediatric SJS-TEN: Where are we now?", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20419/22442")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22442");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "69407": 1,
                           "69406": 4,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "775125fb-66f9-4058-b4b0-4703e4828e2f";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-982.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-982.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-982.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-982.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-982.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>